Signal minus 1: a key factor in immunological tolerance to tissue-specific self antigens?

Immunology and Cell Biology
C R Parish

Abstract

Recent data suggest that many autoreactive T cells, particularly to tissue-specific self antigens, can escape thymic deletion. The current dogma is that these autoreactive T cells are silenced by the failure of most tissues to provide co-stimulation (signal 2), antigen alone (signal 1) inducing T cell unresponsiveness. However, I propose that activation of autoreactive T cells frequently occurs but autodestruction by effector T cells is tightly regulated. This phenomenon is most evident with lymph node metastasizing tumour cells where the regional lymph node can mount a vigorous response to the invading tumour cells but tumour growth is unimpaired. I suggest that autodestruction is prevented by inhibitory receptors on T cells which recognize class I MHC structures on target cells. These receptors, which I propose deliver 'signal minus 1' to T cells, were recently described on NK cells and a subpopulation of peripheral T cells. They are also strikingly similar to a family of anti-self receptors that my laboratory described on murine T and B cells 15 years ago. In the 'signal minus 1' model, antigen-activated T cells acquire the inhibitory receptors when they become co-stimulation independent and gain the ability to exit lymphoid...Continue Reading

References

Jan 1, 1979·Scandinavian Journal of Immunology·H S Warren, K J Lafferty
Jun 1, 1979·The Journal of Experimental Medicine·D PrimiJ W Goodman
Jan 1, 1978·Reviews of Physiology, Biochemistry and Pharmacology·R E Langman
Jul 1, 1977·Developmental and Comparative Immunology·H Kolb
Nov 29, 1978·Biochemical and Biophysical Research Communications·H Kolb, V Kolb-Bachofen
Dec 1, 1992·Current Opinion in Immunology·C C Goodnow
Aug 1, 1989·Immunology Today·A Coutinho, A Bandeira
Jan 1, 1986·Cancer Metastasis Reviews·T Tachibana, K Yoshida
Feb 1, 1988·Immunology and Cell Biology·A M KessonA Mullbacher
Jan 1, 1980·Immunological Reviews·H R MacDonaldK T Brunner
Mar 1, 1980·The Journal of Experimental Medicine·D Y Sia, C R Parish
Oct 1, 1981·European Journal of Biochemistry·D B RylattC R Parish
Nov 16, 1995·Nature·J E Gumperz, P Parham
Apr 1, 1995·Seminars in Immunology·C BottinoA Moretta
Jun 1, 1995·Immunological Reviews·K E HellströmL Chen
Apr 28, 1995·The Journal of Biological Chemistry·J BrennanD L Mager
Jan 1, 1994·Annual Review of Immunology·T BoonA Van Pel
Jan 1, 1994·Annual Review of Immunology·P Matzinger
Dec 1, 1993·Current Opinion in Immunology·B J Fowlkes, F Ramsdell
Jun 1, 1993·Current Opinion in Immunology·C R Mackay
Jan 1, 1993·Immunology Today·B ArnoldG Hammerling
Sep 1, 1995·Current Biology : CB·W M Yokoyama
Feb 1, 1996·Immunology Today·L L Lanier, J H Phillips
Feb 1, 1996·Immunological Reviews·P McCullagh

Citations

Aug 1, 1997·American Journal of Reproductive Immunology : AJRI·D A Clark
Feb 1, 1997·Immunology and Cell Biology·P Price

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.